Meeting News

TAK-788 demonstrates efficacy, manageable safety profile in NSCLC subtype

July 11, 2019
CHICAGO — An oral investigational EGFR/HER2 inhibitor, TAK-788, demonstrated antitumor activity in hard-to-treat patients with non-small cell…
Meeting News

Osimertinib plus chemotherapy tolerable in EGFR-mutated NSCLC

July 10, 2019
CHICAGO — Concurrent treatment with osimertinib and standard chemotherapy did not significantly increase toxicities among patients with…
Meeting News

Capmatinib effective in MET-mutated, advanced NSCLC

July 9, 2019
SAN DIEGO — Phase 2 data from the GEOMETRY mono-1 trial showed that capmatinib was effective and well tolerated in patients with advanced…
Meeting News

Pemetrexed, bevacizumab maintenance therapy benefits certain NSCLC subsets

July 5, 2019
CHICAGO — Adding pemetrexed to continuous maintenance therapy with bevacizumab after induction therapy with carboplatin, pemetrexed and…
Meeting News

Mobile screening unit identifies early-stage lung cancer in underserved populations

July 2, 2019
CHICAGO — Researchers from Atrium Health’s Levine Cancer Institute reported at the ASCO Annual Meeting that a first-of-its-kind mobile CT…
Meeting News

RELAY: Ramucirumab, erlotinib combination improves PFS in EGFR-mutated metastatic NSCLC

June 19, 2019
CHICAGO — The addition of ramucirumab to erlotinib significantly improved the outcomes of patients with EGFR-mutated metastatic non-small…
Meeting News

Early EGFR mutation clearance predicts TKI response in NSCLC

June 17, 2019
CHICAGO — Undetectable EGFR mutations in plasma 3 to 6 weeks after treatment with a tyrosine kinase inhibitor appears to be a prognostic factor…
Meeting NewsVideo

VIDEO: Lung cancer expert reviews ASCO late-breaking trials

June 16, 2019
CHICAGO — In this video, Hossein Borghaei, DO, MS, division chief of thoracic medical oncology at Fox Chase Cancer Center, discusses the…
Meeting NewsVideo

VIDEO: RET inhibitor shows promise in advanced NSCLC

June 15, 2019
CHICAGO — At the ASCO Annual Meeting, HemOnc Today Next Gen Innovator Yanis Boumber, MD, PhD, assistant professor in thoracic medical oncology…
Meeting NewsVideo

VIDEO: KEYNOTE-001 sheds light on ‘big’ question in advanced NSCLC

June 14, 2019
CHICAGO — In this video, Jeffrey P. Ward, MD, PhD, thoracic oncologist at Siteman Cancer Center, Washington University in St. Louis, reviews…